| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.04 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |